What Doctor Prescribes Ozempic for Weight Loss?

Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Any licensed clinician with prescriptive authority can write a prescription for Ozempic — primary care physicians, endocrinologists, obesity medicine specialists, nurse practitioners and physician assistants, depending on state scope-of-practice rules — but the more important fact is that a prescription for weight loss would be an off-label one. The Ozempic prescribing information lists three indications, all of them in adults with type 2 diabetes, and none of them weight management. If weight reduction is the goal, the semaglutide product that carries that approval is Wegovy, and the specialty question matters far less than the indication question.

What Ozempic Is Actually Approved For

The label states three indications: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease; and to reduce the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.

There is no weight-management indication anywhere in that document, and no body mass index eligibility criterion. That is not a technicality. It shapes which diagnosis codes support the prescription, whether a plan will pay, and what evidence the prescriber is relying on.

Which Product Carries the Weight Approval

The Wegovy prescribing information covers the same active ingredient at different dosages and with a different indication set. Wegovy injection is indicated, in combination with a reduced-calorie diet and increased physical activity, to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight; to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 and older with obesity, and in adults with overweight plus at least one weight-related comorbid condition; and for noncirrhotic MASH with moderate to advanced liver fibrosis in adults under accelerated approval.

So the answer to "what doctor prescribes Ozempic for weight loss" is often that the clinician best positioned to help will not prescribe Ozempic for that purpose at all. They will discuss the product whose labeling matches the goal.

Specialty Matters Less Than Evaluation Quality

Obesity medicine is a recognized subspecialty and its practitioners bring depth on nutrition, behavioral factors and pharmacotherapy sequencing. Endocrinologists bring depth on the metabolic and glycemic side. Primary care clinicians bring longitudinal knowledge of the whole patient. Any of these can be the right prescriber.

What distinguishes a good encounter is not the credential on the door. It is whether the clinician takes a real history, reviews the contraindications listed in the label — including personal or family history of medullary thyroid carcinoma and Multiple Endocrine Neoplasia syndrome type 2 — reconciles other medications, and sets up follow-up.

Telehealth Changed Access, Not the Standard

Remote prescribing has substantially widened access, particularly for people without a nearby specialist. The regulatory expectation is unchanged: a licensed clinician, licensed in the relevant state, evaluating a specific patient before prescribing.

The FDA publishes a list of telehealth red flags for consumers, including companies that claim a compounded drug is the same as an FDA-approved drug, offer prices that seem too good to be true, or do not require a screening and prescription by a licensed clinician before providing medicine. Those criteria are a practical filter, and they are set out in the agency's guidance on unapproved GLP-1 drugs.

Where Compounded Semaglutide Fits

Compounded semaglutide is dispensed by a licensed pharmacy pursuant to a prescription for an individual patient. It is a distinct regulatory category: not an FDA-approved finished product, and not reviewed by the FDA for safety, effectiveness or quality before marketing.

It is also not a generic. Neither Ozempic nor Wegovy has an FDA-approved generic, and the FDA has specifically flagged marketing that claims a compounded drug is the same as an approved one. A prescriber who is precise about this distinction is telling you something useful about how they practice.

What to Bring to the Appointment

The evaluation goes faster when the clinician has what they need: a current medication list including supplements, personal and family thyroid history, any history of pancreatitis or gallbladder disease, and a clear statement of what you are trying to achieve.

It also helps to arrive with the indication question already in mind. Asking directly which product is labeled for your goal, and why, moves the conversation past brand names and into the territory where a prescriber can actually be useful.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Which specialists can prescribe Ozempic?

Any licensed clinician with prescriptive authority in your state may write the prescription, including primary care physicians, endocrinologists, obesity medicine specialists, nurse practitioners and physician assistants, subject to state scope-of-practice rules. Specialty matters less than the quality of the evaluation: history, review of labeled contraindications, medication reconciliation and follow-up are what distinguish a sound prescribing decision.

Is Ozempic approved for weight loss?

No. The Ozempic prescribing information lists three indications, all in adults with type 2 diabetes: improving glycemic control as an adjunct to diet and exercise, reducing the risk of major adverse cardiovascular events in those with established cardiovascular disease, and reducing the risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in those with chronic kidney disease. There is no weight-management indication.

Which semaglutide product is approved for weight management?

Wegovy. Its labeling covers reducing excess body weight and maintaining weight reduction long term in adults and pediatric patients aged 12 and older with obesity, and in adults with overweight plus at least one weight-related comorbid condition, in combination with a reduced-calorie diet and increased physical activity. The Wegovy label also carries a cardiovascular risk reduction indication and an accelerated-approval indication in noncirrhotic MASH.

Can a telehealth clinician prescribe semaglutide?

Yes, where the clinician is licensed in the patient's state and conducts an appropriate evaluation. The FDA publishes telehealth red flags worth applying: claims that a compounded drug is the same as an FDA-approved drug, prices that seem too good to be true, and any service that does not require screening and a prescription from a licensed clinician before providing medicine.

Is compounded semaglutide a generic version of Ozempic?

No. Neither Ozempic nor Wegovy has an FDA-approved generic. Compounded semaglutide is prepared by a licensed pharmacy pursuant to a prescription for an individual patient and is not an FDA-approved finished product; the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed. The FDA has specifically warned about marketing that equates the two.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.